methyl gallate has been researched along with Inflammation in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
Candéa, AL; Correa, LB; Costa, TE; Henriques, MG; Pádua, TA; Rosas, EC; Seito, LN; Silva, MA | 1 |
Alencar, LMR; Cordeiro, AS; Corrêa, LB; Gomes-da-Silva, NC; Henriques, MDG; Pereira, LM; Pijeira, MSO; Portilho, FL; Rosas, EC; Santos-Oliveira, R | 1 |
Correa, LB; Cunha, TM; Henriques, MG; Manchope, MF; Rosas, EC; Seito, LN; Verri, WA | 1 |
4 other study(ies) available for methyl gallate and Inflammation
Article | Year |
---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Anti-inflammatory Effect of Methyl Gallate on Experimental Arthritis: Inhibition of Neutrophil Recruitment, Production of Inflammatory Mediators, and Activation of Macrophages.
Topics: Administration, Oral; Animals; Arthritis, Experimental; Brazil; Cyclooxygenase 2; Cytokines; Dose-Response Relationship, Drug; Edema; Gallic Acid; Inflammation; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Macrophages; Mice, Inbred C57BL; Molecular Structure; Neutrophil Infiltration; Nitric Oxide Synthase Type II; Plants, Medicinal; Tumor Necrosis Factor-alpha; Zymosan | 2016 |
Methyl gallate nanomicelles impairs neutrophil accumulated in zymosan-induced arthritis.
Topics: Animals; Arthritis, Experimental; Disabled Persons; Humans; Inflammation; Mice; Motor Disorders; Neutrophils; Tissue Distribution; Zymosan | 2023 |
Methyl gallate attenuates inflammation induced by Toll-like receptor ligands by inhibiting MAPK and NF-Κb signaling pathways.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Edema; Gallic Acid; Hyperalgesia; Inflammation; Male; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; RAW 264.7 Cells; Signal Transduction; Toll-Like Receptors; Zymosan | 2020 |